Menu

Lyra Therapeutics, Inc. LYRA

Full chart Compare
Set alert

Price alert · LYRA

All alert types
0.19 USD 0.00 (+0.00%)

At closeNov 6, 2026, 4:00 PM EST

0.35 +0.16 +84.47%

After hours · Nov 6, 4:00 PM ET

0.3623 Day range 0.52
0.0004 52-week range 4.80
YTD
-93.83%
1 year
-96.12%

Revenue & Expenses

Other Income → Expenses: $2.95MExpenses → Selling, General & Admin: $18.50MExpenses → Research & Development: $43.77MExpenses → Other Operating Expenses: $35.62MExpenses → Income Tax: $39.00KGross Profit → Expenses: $1.53MRevenue → Gross Profit: $1.53MNet Loss → Expenses: $93.44MOther Income$2.95MGross Profit$1.53MNet Loss$93.44MExpenses$97.92MSelling, General & Admin$18.50MResearch & Development$43.77MOther Operating Expenses$35.62MIncome Tax$39.00KRevenue$1.53M

Latest period ending Dec 31, 2024 · select a line to chart its full history

Annual income statement

LYRA annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
1.53M1.56M1.36M285.00K0
1.53M1.56M1.36M285.00K0
1.53M1.56M1.36M285.00K0
97.88M68.68M57.67M43.90M22.21M
43.77M48.03M38.80M29.69M12.52M
18.50M19.06M17.56M14.21M9.69M
-96.35M-67.12M-56.31M-43.62M-22.21M
39.00K59.00K13.00K00
-93.44M-62.68M-55.28M-43.51M-22.13M
-93.44M-62.68M-55.28M-43.51M-22.13M
-93.44M-62.68M-55.28M-43.51M-22.13M
-93.44M-62.68M-55.28M-43.51M-22.13M
-72.00-63.00-92.00-168.00-130.00
-72.00-63.00-92.00-168.00-130.00
-72.00-63.00-92.00-168.00-130.00
-93.40M-62.62M-55.27M-43.51M-22.13M
-93.40M-62.62M-55.27M-43.51M-22.13M
1.30M996.09K604.71K259.72K171.80K
1.30M996.09K604.71K259.72K171.80K